The first major brain tumor breakthrough in decades

Also: Why are health tech leaders taking a risk and openly backing Trump or Harris?

September 13, 2024 Check out STAT+

Sponsored By

José A. Alvarado Jr. for STAT STAT+ | A new drug offers a rare option for brain cancer treatment — and inspires hopes for more FDA-approved last month, the drug from Servier is one of the first major brain tumor breakthroughs in decades, say neuro-oncologists. By Andrew Joseph STAT+ | Insurers went all-in on Medicare Advantage. Now, some are scaling back  Companies like Humana and Aetna rushed in when Medicare Advantage plans were booming. Now they plan to scale back to boost profits. By Tara Bannow STAT+ | FDA approves Roche's injectable version of blockbuster multiple sclerosis drug Patients will be able to get a 10-minute injection, instead of an hours-long infusion. Novartis already has its own injectable MS drug, Kesimpta. By Jonathan Wosen Andrew Harnik/Getty Images STAT+ | Why these health tech leaders are making a risky bet, openly backing Trump or Harris In a stark departure from the past, Silicon Valley startup leaders and investors are picking a side in this year's presidential race. By Mohana Ravindranath STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman STAT+ | Opinion: What does the presidential election mean for ICHRA and the health insurance market? Let's take an early look at how Trump, Harris, and their party platforms might influence the ICHRA market going forward. By Jack Hooper NIAID Inquiry into unexplained bird flu case in Missouri broadens to a close contact There were overlapping illnesses between the patient whose H5 flu is unexplained and a close contact; no connection yet determined. By Helen Branswell

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser